


NEUROSTECH
Biotechnology Research • Llanera, Principality of Asturias, Spain • 1-10 Employees
Company overview
| Headquarters | Llanera, Principality of Asturias, Spain |
| Phone number | +34985980098 |
| Website | |
| NAICS | 541714 |
| Keywords | Biotech, Alzheimer, Drug Delivery, Medtech, ELA, Parkinson, Neurodegenerative Disease, Blood-Brain Barrier, Intrathecal Delivery, Amyloid |
| Founded | 2020 |
| Employees | 1-10 |
| Socials |
Key Contact at NEUROSTECH
Gabriel Álvarez Menéndez
Co-Founder & Ceo
NEUROSTECH Email Formats
NEUROSTECH uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@neurostech.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@neurostech.com | 100% |
About NEUROSTECH
NEUROSTECH is the world’s only biotechnology company that has designed, patented, tested, and developed human prototypes of fully implantable pumpless devices and smart catheters for the controlled intrathecal delivery of drugs. We harness cerebrospinal fluid (CSF) dynamics to create innovative medical devices that deliver targeted, precise treatment exactly where it is needed. NEUROSTECH’s expertise in bioengineering supports a proprietary pipeline of medical devices, which are approaching clinical trials for neurological conditions. NEUROSTECH provides the safest solutions for novel treatment approaches in neurodegenerative diseases, addressing unmet medical needs for devastating conditions such as Alzheimer’s, Parkinson’s, ALS, and more _________________ TECHNOLOGY Cerebrospinal fluid (CSF) naturally flows through the brain in rhythmic, pulsing waves, creating pressure differentials along the intrathecal space. NEUROSTECH is a global leader in leveraging CSF dynamics to develop innovative medical devices. By harnessing the natural flow of CSF, NEUROSTECH is pioneering the development of groundbreaking medical devices. Our deep understanding of CSF dynamics allows us to design the next generation of intrathecal catheters that power pumpless devices. NEUROSTECH also develops advanced subcutaneous reservoirs with cutting-edge architecture and user-friendly percutaneous ports. Through precise engineering of nanoporous membranes, we achieve full control over selective molecular permeability. _________________ PIPELINE Fully implantable pumpless intrathecal devices enable two key modalities: --> Clearance of toxic molecules from the CNS by intrathecal pseudo-delivery --> Controlled intrathecal drug delivery for optimized distribution of therapies to the CNS Smart catheters for CSF management systems: --> Stand-alone lumbar drainage --> Systems combined with external filter devices for CSF filtration (extracorporeal liquorpheresis)
NEUROSTECH revenue & valuation
| Annual revenue | $684,440 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,200,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
NEUROSTECH has 4 employees across 4 departments.
Departments
Number of employees
Funding Data
NEUROSTECH has never raised funding before.
NEUROSTECH Tech Stack
Discover the technologies and tools that power NEUROSTECH's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript libraries
Cookie compliance
Maps
JavaScript libraries
JavaScript libraries
Web servers
JavaScript libraries
Programming languages
WordPress plugins
Blogs
Analytics
Frequently asked questions
4.8
40,000 users



